双层光谱CT物质分解定量脑钙化进展在原发家族性脑钙化中的附加价值
体模研究验证双层光谱CT物质分解测量钙化质量的准确性(中位误差≤5.0%),并前瞻性纳入25例PFBC患者(CALCIFACT队列)行两次双层CT扫描。钙化质量年进展率4.6%(P<0.001),高于体积测量2.5%(P=0.16)和视觉评分0.0%(P=0.043),提示物质分解质量测量可能更敏感。
要点
- 物质分解钙化质量测量在体模中准确(中位误差≤5.0%),可用于临床连续监测。
- PFBC钙化质量年进展率4.6%,高于体积2.5%和视觉评分,敏感性更优。
- 体积和视觉评分在随访1.1年内进展有限,报告进展时应结合质量测量。
关键影像表现/征象
- PFBC患者脑钙化在常规CT重建上以视觉分级评分和体积测量评估,体积和质量测量阈值均为>60 HU。
- 钙化质量通过光谱数据物质分解获得,体模中最大中位测量误差为2.1%和5.0%,六次重复采集误差范围0.9%。
诊断标准与关键数值
- 钙化质量年进展率为4.6%(IQR 1.1-6.5),Wilcoxon符号秩检验P<0.001。
- 钙化体积年进展率为2.5%(IQR -2.5-6.5),P=0.16。
- 视觉钙化评分年进展率为0.0%(IQR 0.0-0.0,最小-最大0-53.6),P=0.043。
- 体积和质量测量均采用>60 HU阈值。
临床应用与阅片要点
- 对PFBC患者随访时,可尝试用双层光谱CT物质分解测量钙化质量,比视觉评分和体积更易检出进展。
- 阅片报告可同时记录视觉评分、体积和质量,注意体积测量可能因阈值和分割差异而不敏感。
- 体模验证显示质量测量重复性较好,但临床解读需结合随访间隔(中位1.1年)和个体变化。
局限性
- 临床样本量较小(25例),随访时间较短(中位1.1年)。
- 为单队列前瞻性研究,需外部验证。
- 体模研究仅评估两台双层CT,其他设备适用性未验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the feasibility and potential added value of spectral CT-based material decomposition to quantify brain calcification progression in patients with PFBC.
METHODS: First, a phantom study was performed to assess the accuracy of two dual-layer CT scanners (CT7500, IQon, Philips Healthcare) for mass measurement. Second, PFBC patients from the CALCIFACT cohort study who underwent two dual-layer CT scans between January 2022 and November 2024 were prospectively included. Calcification burden was measured with a visually graded calcification score and with volume measurements on conventional CT reconstructions. Mass measurements were performed with material decomposition using spectral data. For the volume and mass measurements a threshold of > 60 HU was applied. The significance of annual progression was tested using Wilcoxon signed-rank test.
RESULTS: In the phantom study, calcification mass showed maximum median measurement errors of 2.1% and 5.0% for two scanners with a limited range in measurement errors of 0.9% for six repeated acquisitions. 25 patients (mean age, 55 years ± 17 (SD); 52% male) were included in the clinical study. Follow-up duration was 1.1 years (IQR 0.7 - 1.4). Calcification mass showed the greatest increase with an annual progression rate of 4.6% (IQR 1.1-6.5) (P < 0.001). Calcification volume (2.5% (-2.5 - 6.5) (P = 0.16)) and visual calcification score (0.0%, IQR 0.0 - 0.0, min-max 0-53.6) (P = 0.043) showed less progression.
CONCLUSION: Calcification mass measurement using material decomposition is an accurate and feasible method, and may be more sensitive to calcification progression on brain CT in PFBC compared with visual scoring and volumetric quantification.
引用
- van der Star S, Allaerts N, Koek HL, et al. Added value of material decomposition for measuring brain calcification progression with spectral computed tomography in primary familial brain calcification. Eur J Radiol. 2026. PMID: 42691747. doi:10.1016/j.ejrad.2026.113188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。